FERRONE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 8.202
AS - Asia 3.883
EU - Europa 3.647
SA - Sud America 481
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 16.311
Nazione #
US - Stati Uniti d'America 8.125
SG - Singapore 1.486
CN - Cina 932
SE - Svezia 822
UA - Ucraina 737
IT - Italia 428
BR - Brasile 371
VN - Vietnam 349
HK - Hong Kong 344
FI - Finlandia 332
KR - Corea 303
DE - Germania 281
FR - Francia 263
GB - Regno Unito 144
PL - Polonia 130
TR - Turchia 129
RU - Federazione Russa 127
BG - Bulgaria 111
IE - Irlanda 107
IN - India 70
BD - Bangladesh 47
AR - Argentina 45
MY - Malesia 41
NL - Olanda 34
BE - Belgio 33
CA - Canada 33
IQ - Iraq 33
CH - Svizzera 28
JP - Giappone 26
ZA - Sudafrica 21
MX - Messico 18
EC - Ecuador 17
UZ - Uzbekistan 16
MA - Marocco 15
CO - Colombia 14
CZ - Repubblica Ceca 13
KE - Kenya 12
PH - Filippine 12
PK - Pakistan 11
EG - Egitto 10
ID - Indonesia 9
JO - Giordania 9
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
ES - Italia 8
PY - Paraguay 8
TH - Thailandia 8
DZ - Algeria 7
IL - Israele 7
KZ - Kazakistan 7
EU - Europa 6
LT - Lituania 6
RO - Romania 6
ET - Etiopia 5
HN - Honduras 5
JM - Giamaica 5
KG - Kirghizistan 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
SA - Arabia Saudita 4
SN - Senegal 4
TW - Taiwan 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BB - Barbados 3
GR - Grecia 3
IR - Iran 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
TN - Tunisia 3
AO - Angola 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LV - Lettonia 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
Totale 16.299
Città #
Woodbridge 1.206
Ann Arbor 1.120
Singapore 838
Jacksonville 627
Houston 588
Ashburn 562
Chandler 507
San Jose 474
Fairfield 363
Hong Kong 343
Seoul 301
Hefei 277
Wilmington 273
Beijing 219
Princeton 210
Boardman 185
Seattle 149
Chicago 134
Ho Chi Minh City 113
Cambridge 110
Columbus 110
Sofia 110
Helsinki 108
Dublin 104
Zgierz 103
Lauterbourg 99
Los Angeles 86
Izmir 85
Hanoi 71
Düsseldorf 65
Buffalo 63
Moscow 62
Milan 60
Munich 59
Dearborn 57
The Dalles 53
Dallas 44
Frankfurt am Main 43
Falkenstein 42
New York 39
San Diego 39
São Paulo 36
Redwood City 34
Bremen 33
Brussels 33
Kocaeli 29
Orem 29
Chennai 28
Santa Clara 28
Trieste 26
Bern 23
Tokyo 23
Warsaw 23
Verona 22
Haiphong 19
Shanghai 19
Des Moines 16
Falls Church 16
Guangzhou 16
Nanjing 16
Phoenix 16
Amsterdam 15
Da Nang 14
Redondo Beach 14
Turku 14
Brno 12
Montreal 12
Mumbai 12
Tashkent 12
Belo Horizonte 11
London 11
Nairobi 11
Norwalk 11
Casablanca 10
Jinan 10
Quito 10
Rio de Janeiro 10
Rome 10
Tianjin 10
Amman 9
Brooklyn 9
Charlotte 9
Florence 9
Johannesburg 9
Baghdad 8
Brasília 8
Curitiba 8
Manchester 8
Toronto 8
Biên Hòa 7
Boston 7
Can Tho 7
Cape Town 7
Denver 7
Fremont 7
Grafing 7
Kunming 7
Nanchang 7
Poplar 7
Shenzhen 7
Totale 10.957
Nome #
POLIMERI IN MEDICINA I DENDRIMERI, UN ESEMPIO DI MOLECOLE BIOTECNOLOGICHE 272
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 266
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 259
Analogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach 259
Binding at the core. Computational study of structural and ligand binding properties of naphthiridine based dendrimers 252
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 225
C-kit mutants in GISTs and their interaction with STI 571: Insights from computer simulations and clinical trials. 219
"Fatty" nucleoside analogs as HCV NS5b inhibitors 218
T670X kit mutations in gastrointestinal stromal tumors: making sense of missense 212
A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors 208
Functional analysis and molecular modelling show a preserved wild type activity of p53 C238Y 206
Many-Scale Simulation of ABS/PC Blends for the Automotive Industry 205
A new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: A coupled experimental and modeling investigation 197
Chemical Engineering at the edge of life science. Selected cases of molecular simulations and free-energy calculations for biological and medical applications. 195
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 192
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 191
Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm 190
PET/PEN Blends of Industrial Interest as Barrier Materials. Part I. Many-Scale Molecular Modeling of PET/PEN Blends 185
Computer simulation of polypropylene/organoclay nanocomposites: characterization of atomic scale structure and prediction of binding energy 185
A new twist for an old song. The DABO story revisited 185
Synthesis and physico-chemical characterization of folate-cyclodextrin bioconjugate for active drug delivery 184
A cyclodextrin-bioconjugate as carrier for anticancer drugs: from synthesis to molecular modeling 184
Functional analyses and Molecular modeling of two c-Kit mutations responsible for Imatinib secondary resistance in GIST patients 183
Integrated process of design, synthesis and physicochemical characterization of nanovectors for active drug delivery: the cyclodextrin-folate-bioconjugate example 180
Design, synthesis and activity of hindered nucleoside analogs with anti-Flaviviridae activity, and their interaction with RdRp 178
Design, synthesis and preliminary in vitro and in silico antiviral activity of [4,7]phenantrolines and 1-oxo-1,4-dihydro-[4,7]phenantrolines against a single-stranded positive sense RNA genome viruses 177
Can inhibitors of HIV integrase work on HCV polymerase? 177
Computer Simulation of nylon/organoclay nanocomposites: prediction of the binding energy 176
Design, synthesis and characterization of folate-cyclodextrin bioconjugate for active drug delivery: results from combined computational and experimental efforts 174
Computer simulation of polymer-organoclay nanocomposites for packaging applications: From binding energy to interlayer spacing predictions 173
Upgrading polymeric materials from post industrial rejects: a multiscale simulation approach 173
Diblock copolymers for the automotive industry: the mesoscopic approach 173
Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer. 172
A talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding 171
A Tumor (GIST), a Mutated Gene (c-kit), and a Molecular Inhibitor (Imatinib): Insights from Computer Simulations 170
Fighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm 170
Grand canonical Monte Carlo simulations for VOCs adsorption in non-polar zeolites 169
TT315I mutated bcr-abl in chronic myeloid leukemia and imatinib: insights from a computational study 166
Computer-aided simulation of a dendrimer with a protoporphyrinic core as potential, novel hemoprotein mimic. 165
Molecular Simulation of Atrazine Adhesion and Diffusion in a Saturated Sand Model 165
Studying enzyme enantioselectivity using combined ab initio and free energy calculations: alfa-chymotrypsin and methyl cis- and trans-5-oxo-2-pentylpirrolidine-3-carboxylates 164
Delivered to Perfection at Nanoscale. A Coupled Multiscale Simulation/Experimental Investigation of Protein Release from Nanochannel Delivery Systems 164
Alternative Refrigerants: Thermophysical Properties and Phase equilibra by computational chemistry 164
Design, synthesis and anti flaviviridae activity of N6-, -O- and 5 O-substituted adenine nucleoside analogs 162
Chasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants 162
Three-dimensional, nanosized phenylene-based dendrimers: scaling properties studied by a computational approach 161
Nanocompositi: da micro a mesoscala 160
New materials from multiscale modelling procedures: properties prediction and customisation of polymeric nanocomposites 158
Polymer-Clay Nanocomposites Based on PEO-Diacrylate Macromolecules: a Combined Computational/Experimental Study 157
Genotype-phenotype correlations of myosin mutations: a molecular simulation study 157
Development of an all-atoms force field from ab-initio calculations for alterative refrigerants 156
Multiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations 156
Computational studies on the enantioselectivity of alpha-chymotrypsin towards beta-carbomethoxy-gamma-lactams. 154
Nano-scaled inorganic/biopolymer composites: Molecular modeling vistas 154
Changes and challenges: GIST, mutated C-KIT and imatinib resistance 154
GCMC Simulations in Zeolite MFI and Activated Carbon for Benzene Removal from Exhaust Gaseous Streams 151
Prediction fo HIV-1 resistance to NNRITs: a computer-aided molecular-based rationale 150
Innovative procedures based on advanced mesoscale simulation techniques for functional polymers in automotive industry 147
Enantiomerically pure beta,gamma-disubstituted gamma-lactams: Enzyme-mediated synthesis and computational studies 147
Release of Proteins from Nanochannel Delivery Systems: a Coupled Many-Scale Simulation - Experimental Investigation 144
Simulation insight on the structure and energetics of biocompatible polymer nanocomposite systems 144
How the Angstrom modifies the nano: effect of point mutations on the nanodimensional structure of human TP53 point mutations 143
Probing the activity of diketoacis as HCV NS5B polymerase inhibitors via detailed molecular modeling 143
Hydrogen sulphide removal from biogas by zeolite adsorption: part I. GCMC molecular simulations 140
SYNTHESIS AND ANTI-PICORNAVIRIDAE IN VITRO ACTIVITY OF A NEW CLASS OF HELICASE INHIBITORS THE N,N’-BIS-[4-1H(2H)-BENZOTRIAZOL-1(2)-YL)PHENYL] ALKYLDICARBOXAMIDES. 138
Modellazione molecolare e progettazione di nuovi inibitori della serin proteasi NS3 del virus dell’HCV 138
Scaling properties in the molecular structure of three-dimensional, nanosized phenylene-based dendrimers as studied by atomistic molecular dynamics simulations 137
PVC/LDPE incompatible blends for industrial applications: A computational multiscale approach 136
Molecular modeling of Nylon 6/organoclay nanocomposite: prediction of binding energy 135
Where are we in HIV research? A novel, computer-based strategy predicting resistance to HIV-1 NNRTIs 135
Human TP53 point mutations: structural analysis by molecular modelling 135
Shape-persistent polyphenylene-based dendrimers: a computational approach 134
Of life and Death: Chronic Myeloid Leukemia and the Bcr-Abl/Imatinib Paradigm 134
Take a walk on the nano side: structural and energetical analysis of ATP-binding pocket mutations of the cardiac beta-myosin heavy chain implicated in familial hypertrophic cardiomyopathy 131
Odor emission removal from gaseous streams by the use of zeolites: A molecular simulation approach 130
Estimation of the binding energy in random poly(butylene terephtalate-co-thiodiethylene terephtalate) copolyesters/clay nanocomposites via molecular simulations 128
Molecular modeling of hydrogen storage in carbon nanotubes: A combined molecular dynamics/ab initio orbital study 128
Using of MM-PBSA in reproducing the binding free energy of NSAIDS to beta-cyclodextrin. 127
P53 mutations in sporadic and NF1 related malignant peripheral nerve sheath tumors (MPNST): from clinical evidences to a molecular rationale 127
Computational studies of shape-persistent polyphenylene dendrimers 127
Synthesis of a New Series of Nucleoside Analogs with Antiflaviviridae Activity and Their Interaction with RNA-Dependent RNA-Polymerase 127
Hydrogen sulphide removal from biogas by zeolite adsorption: part II. A MD simulation 126
Enantioselectivity of alpha-chytripsyn towards 4,5-disubstituted-gamma-lactams: a new perspective from molecular simulations 126
Molecular simulation techniques for sustainable technology and environmental applications: general overview and case studies 125
Computational alanine scanning to probe DNA - Wild type and mutant p53 interactions. 123
Shape-persistent polyphenylene dendrimers: a computational study 121
Molecular dynamics and free energy analyses of the interactions between beta-cyclodextrin and some anticancer drugs. 119
Synthesis, characterization and molecular modeling of a cyclodextrin-bioconjugate as anticancer drug 119
Three-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase 118
Upgrading block co-polymers from post industrial rejects: a multiscale simulation approach 117
Design, synthesis and activity of phosphonoacetic acid (Ppa) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors 116
Host-guest inclusion complexes between anticancer drugs and beta-cytclodextrin: computational studies. 116
Prediction of thermophysical properties of alternative refrigerants by a novel, ab initio force field 115
Computer-assisted design of new, potential HCV inhibitors 115
Detailed Molecular Modeling of Point Mutations of P53 114
Towards Dendrimers as Anticancer Drug Carriers: from in Silico to in Vivo Characterization 113
Hindered Nucleoside Analogs (HNA) as Antiflaviviridae Agents 110
Diffusion of proteins in nanochannels. A many-scale simulation approach 110
Is tailor-fitting always the best choice? The case of mutations in GISTs and Imatinib 106
Nylon-6/organoclay nanocomposites: prediction of the binding energy by molecular simulation 106
Totale 15.955
Categoria #
all - tutte 48.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.128 20 100 112 135 13 84 44 41 172 114 52 241
2022/20231.542 141 148 112 207 227 257 13 113 207 16 74 27
2023/2024684 67 48 39 55 86 39 72 154 6 8 43 67
2024/20251.886 41 24 60 199 238 219 126 81 272 206 162 258
2025/20264.786 469 346 342 445 425 498 582 167 617 671 123 101
Totale 16.424